Royal Bank of Canada Boosts Jamieson Wellness (TSE:JWEL) Price Target to C$41.00

Jamieson Wellness (TSE:JWEL) had its target price lifted by analysts at Royal Bank of Canada from C$38.00 to C$41.00 in a report released on Tuesday,BayStreet.CA reports. The firm presently has an “outperform” rating on the stock. Royal Bank of Canada’s target price would suggest a potential upside of 27.05% from the company’s current price.

Several other equities analysts have also weighed in on the stock. BMO Capital Markets lifted their target price on shares of Jamieson Wellness from C$42.00 to C$46.00 in a report on Thursday, December 19th. National Bankshares raised their price objective on shares of Jamieson Wellness from C$36.50 to C$42.00 in a research note on Monday, November 25th. Finally, TD Securities raised their price objective on shares of Jamieson Wellness from C$40.00 to C$42.00 and gave the company a “buy” rating in a research report on Friday, November 8th.

Jamieson Wellness Trading Up 1.1 %

Shares of JWEL traded up C$0.34 during mid-day trading on Tuesday, hitting C$32.27. The company had a trading volume of 27,216 shares, compared to its average volume of 62,980. The stock has a market cap of C$1.35 billion, a PE ratio of 33.91 and a beta of 0.63. The business’s 50-day simple moving average is C$34.53 and its 200-day simple moving average is C$34.28. Jamieson Wellness has a 1-year low of C$23.98 and a 1-year high of C$38.20. The company has a quick ratio of 1.08, a current ratio of 2.76 and a debt-to-equity ratio of 75.70.

Insider Activity

In related news, Senior Officer Regan Stewart sold 1,300 shares of the company’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of C$37.84, for a total transaction of C$49,192.00. 0.26% of the stock is currently owned by corporate insiders.

Jamieson Wellness Company Profile

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.